In the case of Alzheimer’s disease, a chimeric AAV2/5 vector with the AAV2 genome and the AAV5 capsid structure has been applied for the expression of the nerve growth factor (NGF) [221]. Here, NGF is linked to early-onset autosomal dominant Alzheimer disease.